Top Markets
Coin of the day
Syntara Limited Syntara Limited

Syntara Limited

SNT
Rank in Stocks #28269
Syntara Limited is a clinical-stage biopharmaceutical company dedicated to... Syntara Limited is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies by targeting extracellular matrix dysfunction, primarily through amine oxidase chemistry. Headquartered in Frenchs Forest, Australia, the company's research pipeline focuses on blood cancers as well as a range of inflammatory and fibrotic disorders. Its leading investigational compound, amsulostat, is currently in Phase 1c/2 clinical trials for the treatment of myelofibrosis, a bone marrow cancer, and is also being evaluated for myelodysplastic syndrome. Beyond this, Syntara is advancing several other promising drug candidates. These include a suite of topical pan-LOX inhibitors: SNT-9465, which is undergoing Phase 1a/b study for hypertrophic scars, and SNT-6302, designed for keloid scars. Furthermore, SNT-4728 is in development to manage sleep disorders and to potentially slow the progression of neurodegenerative conditions by mitigating neuroinflammation. The company's broader therapeutic ambitions extend to various fibrotic and inflammatory diseases such as kidney fibrosis, MASH (metabolic dysfunction-associated steatohepatitis), pulmonary fibrosis, and cardiac fibrosis. Incorporated in 1998, the company was formerly known as Pharmaxis Ltd before adopting the name Syntara Limited in December 2023.
Share Price
$0.0183374
Market Cap
$27.51M
Change (1 day)
0.00%
Change (1 year)
9.62%
Country
AU
Trade Syntara Limited (SNT)

Category

Stock price history for Syntara Limited (SNT)
Highest end of day price: $0.02 on 2026-08-01

Lowest end of day price: $0.28 on 2003-11-01
Stock price history of Syntara Limited from 2003 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -1.09%
2025 -51.46%
2024 153.74%
2023 -58.49%
2022 -59.91%
2021 52.34%
2020 -53.70%
2019 -23.78%
2018 -2.79%
2017 0.17%
2016 -3.02%
2015 255.75%
2014 -40.87%
2013 -92.56%
2012 20.50%
2011 -60.61%
2010 14.15%
2009 213.96%
2008 -78.00%
2007 51.46%
2006 56.14%
2005 152.82%
2004 102.33%
2003 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$164.10 26.13%
DE
$37.95 22.53%
JP
$222.33 34.29%
CH
$20.95 11.61%
IN